Oculopharyngeal Muscular Dystrophy is an inherited disorder that causes muscle weakness. Onset of symptoms of Oculopharyngeal muscular dystrophy begins in adulthood, usually after age 40, with difficulty swallowing. The symptoms worsen over time and can spread to proximal muscles such as the upper legs and hips. Oculopharyngeal muscular dystrophy is caused by a mutation to the PABPN1 gene. There is no cure for Oculopharyngeal muscular dystrophy, but treatment options include surgery to make eating and swallowing easier and gene therapy.
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Muscular Dystrophy, Oculopharyngeal below!
For more information on how to use Laverne, please read the How to Guide.
We have 580 products for the study of Muscular Dystrophy, Oculopharyngeal that can be applied to Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.